High-throughput technology will dramatically advance and reduce timeframe for bringing valuable, commercial hemp/cannabis plant lines and intellectual property to market...
New partnership seeks to reduce perinatal mood disorders, focus on the use of breastmilk, and provide essential guidance for families...
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune...
Philips Disney Ambient Experience Ariel and Nemo Philips Disney Ambient Experience Mickey Mouse Philips Disney Ambient Experience Yoda Philips MR...
SPARTA, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty...
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the “Company” or “PureK”) (TSX Venture: PKAN) is...
NOVATO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
PHILADELPHIA, PA, March 03, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical...
San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
HOUSTON, March 03, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, Chief Executive...
Trial funded in part by a National Institute on Aging Small Business Innovation Research (SBIR) Grant Trial objectives include evaluation of...
BASKING RIDGE, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical...
Extends Veverimer Patent Protection into 2038SOUTH SAN FRANCISCO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical...
Conference Call to Discuss Results on March 11, 2021 at 8:00 a.m. ETWARSAW, Ind., March 03, 2021 (GLOBE NEWSWIRE) --...
Transformative steps reduce debt by approximately $256 million and include an immediate $50 million capital investmentOpportunity for an additional $25...
New York, NY, March 03, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that...
OTTAWA, March 03, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release...
OLD GREENWICH, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the...